Algernon – CFN Media

Top News

Algernon Pharmaceuticals Announces Launch of Rights Offering

VANCOUVER, British Columbia, March 21, 2023 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE:…

Ryan Allway
March 21, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Cardiol Wraps Up One Phase 2 Trial, Preparing for Phase 3

Small pharmaceutical developers have been responsible for the clinical trials of the…

Robin Lefferts
September 17, 2024

Lithium South Development Announces Completion of Phase I Environmental Baseline Study and Progress on Phases II and III

VANCOUVER, BC, Sept. 12, 2024 /CNW/ — Lithium South Development…

Ryan Allway
September 12, 2024

Healthcare Stocks

Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024

Full clinical data will be reported in an oral presentation at the…

Ryan Allway
September 10, 2024

Aduro Enters Another Multi-Billion Dollar Market

For Aduro Clean Technologies, Inc. (CSE: ACT) (OTCQB: ACTHD) (FSE: 9D5), recycling…

Ryan Allway
September 5, 2024